Related Experiment Video
Updated: May 5, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.8K
[Neonatal hyperthyroidism: clinical pattern and therapy]
S Petignot1, K Nyamugabo, H Valdes Socin
1Université de Liège, Belgique.
Revue Medicale De Liege
|December 5, 2013
Summary
Neonatal hyperthyroidism, often caused by maternal Graves' disease, affects 1-2% of infants born to affected mothers. This study reviews four cases and discusses updated management strategies from fetal development through birth.
Area of Science:
- Endocrinology
- Neonatology
- Obstetrics
Background:
- Neonatal hyperthyroidism is a rare condition, frequently linked to maternal Graves' disease.
- Graves' disease affects approximately 0.2% of pregnant women.
- Infants born to mothers with Graves' disease have a 1-2% risk of developing neonatal hyperthyroidism.
Observation:
- This article presents a retrospective review of four neonatal hyperthyroidism cases diagnosed and treated at CHU-NDB between 2007 and 2011.
- The cases highlight the clinical presentation and management of affected neonates.
Findings:
- The study details the diagnostic and therapeutic approaches used for these four infants.
- It provides insights into the practical management of neonatal hyperthyroidism in a clinical setting.
Implications:
- Updated recommendations for managing neonatal hyperthyroidism from the fetal stage to birth are discussed.
- This review aims to inform clinical practice and improve outcomes for affected neonates and their mothers.
- The findings contribute to the evolving understanding of neonatal hyperthyroidism management protocols.
Related Concept Videos
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Hypothyroidism II: Pathophysiology
26
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K

